Aurobindo Pharma Ltd.

AUROPHARMA

Market Cap
₹61,110 Cr.
P/E
26.28

Aurobindo Pharma Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years due to earnings
ROE
ROE has decreased vs 10 year trend
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a premium to 3yr historic valuations
Promoter Holding
Promoter has not sold any shares in the last 90 days
ROE
Latest
7.18%
3yr Average
14.09%
5yr Average
15.24%
Net Profit Margin
Latest
7.75%
3yr Average
13.53%
5yr Average
13.0%
ROCE
Latest
9.97%
3yr Average
14.84%
5yr Average
18.44%
Debt to Equity
Latest
0.18
3yr Average
0.17
5yr Average
0.27
Market Share
6.80% (as of Mar 21)
Rx Market Share - USA
locked Source
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up -API

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Dosage Form Break-Up -USA Formulation

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (No)
      Source
    • Europe DMF Filings (No)
      Source
    • Number of ANDA's Filed in USA (Nos)
      Source
    • Number of ANDA's Approved By USFDA (Nos)
      Source
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Aurobindo Pharma Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline
    Sign Up for Free